Education & Publications
ICR organizes scientific conferences, workshops, and training programs for healthcare professionals and researchers.
References
Toward an anandamide transporter
Proc Natl Acad Sci U S A. 2005;102(49):17541–17542.
doi:10.1073/pnas.0508644102
FABP1 and hepatic Δ9‑THC transport
Elmes MW, Prentis LE, McGoldrick LL, Giuliano CJ, Sweeney JM, Joseph OM,
Che J, Carbonetti GS, Studholme K, Deutsch DG, Rizzo RC, Glynn SE, Kaczocha M.
FABP1 controls hepatic transport and biotransformation of Δ9-THC.
Sci Rep. 2019;9:7588. doi:10.1038/s41598-019-44108-3
Endocannabinoid tone vs. constitutive receptor activity
Howlett AC, Reggio PH, Childers SR, Hampson RE, Ulloa NM, Deutsch DG.
Endocannabinoid tone versus constitutive activity of cannabinoid receptors.
Br J Pharmacol. 2011;163(7):1329–1343.
doi:10.1111/j.1476-5381.2011.01364.x
A critical review of anandamide transport
Glaser ST, Kaczocha M, Deutsch DG. Anandamide transport: a critical review.
Life Sci. 2005;77(14):1584–1604.
doi:10.1016/j.lfs.2005.05.007
Elevating anandamide: a personal retrospective
Deutsch DG. A Personal Retrospective: Elevating Anandamide (AEA) by Targeting
Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs).
Front Pharmacol. 2016;7:370. doi:10.3389/fphar.2016.00370
Design of on‑target FAAH inhibitors
Deutsch DG. Design of on-target FAAH inhibitors.
Chem Biol. 2005;12(11):1157–1158.
doi:10.1016/j.chembiol.2005.11.001